報價延遲最少15分鐘:2025/06/01 05:22 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.2132 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.18/-10.80
|
|
企業價值
14.76M
|
| 資產負債 |
|
每股賬面淨值
-0.10
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
68.00K
|
|
每股收益
1.95
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/01 05:22 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting. |